ALM vs MEOH

ALM's deterministic health scores signal severe financial distress: the Piotroski F-Score of 1/9 indicates extreme weakness in operational and financial health, while the absence of an Altman Z-Score raises unquantified bankruptcy risk. Despite strong revenue growth (28% YoY) and a bullish analyst consensus (strong_buy), the company reports a negative profit margin (-216.27%), negative ROE (-57.31%), and negative earnings, rendering valuation metrics like Forward P/E (87.79) and Price/Book (31.95) meaningless. The stock trades at a massive premium to its fundamentals, with no intrinsic value or Graham Number available, suggesting speculative pricing. Insider activity is neutral, and the recent 20.2% one-week decline underscores high volatility and potential overvaluation.

MEOH exhibits a severe disconnect between its current market price ($59.75) and its fundamental value, with a Piotroski F-Score of 4/9 indicating only stable health and a Graham Number of $25.71 suggesting significant overvaluation. While the stock has seen a massive 123% 1-year price surge, this is not supported by fundamentals, as YoY EPS growth has plummeted by 111.3% and profit margins have shrunk to a razor-thin 2.22%. The high payout ratio (79.57%) combined with declining earnings creates a risk to dividend sustainability. Despite analyst 'buy' ratings, the deterministic metrics signal a speculative bubble or an over-optimistic anticipation of a cyclical recovery.